Invest in IPO

Bliss GVS Pharma Ltd

  • BSE Code : 506197
  • NSE Symbol : BLISSGVS
  • ISIN : INE416D01022
  • Industry :PHARMACEUTICALS - INDIAN - FORMULATIONS

up-arrow 119.36 0.55(0.46%)

Open Price ()

118.81

Prev. Close ()

118.81

Volume (No’s)

47,936

Market Cap ()

1,251.90

Low Price ()

118.61

High Price ()

120.74

 

Book Closure

From Date To Date Announcement
01-Apr-2025 NA We would like to inform you that, the Board Meeting of the Company was held today i.e. Thursday, May 02, 2024 at the registered office of the Company. In pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has considered and approved the matters amongst others as attached.
20-Mar-2025 NA Vibha Gagan Sharma & PACs (Acquisition Dated on: 20.03.2025 & 21.03.2025)
18-Feb-2025 NA Narsimha Shiboor Kamath (Acquisition Dated on: 18.02.2025 & 19.02.2025)
30-Jan-2025 NA Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursday, January 30, 2025 Name of the Company Bliss GVS Pharma Limited ISIN INE416D01022 Scrip Code 506197 No of Shares 4000 Face Value 1 Dist Nos.From 105366273 Dist Nos.To 105370272 Date Upto Which Under lock-in 07-Jul-25
28-Jan-2025 NA BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 inter alia to consider and approve The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2024; and The proposal for issuance of Sweat Equity Shares pursuant to applicable provisions of the Companies Act 2013 the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations 2021 and other applicable laws and regulations to Key Managerial Personnel and/or Senior Management Personnel and/or Employee(s) of the Company including determination of the issue price if any subject to such regulatory and statutory approvals as may be required including approval of the shareholders of the Company. Please find the attached Outcome of Board Meeting held on Tuesday, January 28, 2025. (As Per Bse Announcement Dated on 28.01.2025)

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew